Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- CheckyesterdayChange DetectedThe record history shows a new revision labelled v3.5.0 and removes v3.4.3, updating the displayed version history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedNew revision label v3.4.2 appears and v3.4.1 is removed on the history page; no substantive study data or functionality is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe history shows a new revision label (v3.4.1) replacing v3.4.0. This is a minor metadata update and does not change study data or content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe Record History page adds a 'Show glossary' option and uses green highlights for additions and red highlights for deletions to indicate changes; revision notes show a new version v3.4.0 and adjust the wording of the FEAR Act data line.SummaryDifference1%

- Check66 days agoChange DetectedThe Record History now includes a new revision entry v3.3.4 and removes v3.3.3, reflecting internal version tracking. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.